Cargando…

Altered immunoglobulin G glycosylation in patients with isolated hyperprolactinaemia

Prolactin is a peptide hormone produced in the anterior pituitary, which increase in several physiological and pathological situations. It is unclear if hyperprolactinaemia may affect glycosylation of immunoglobulin G (IgG). Twenty-five patients with hyperprolactinemia and 22 healthy control subject...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirschberg, Daniel, Ekman, Bertil, Wahlberg, Jeanette, Landberg, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909626/
https://www.ncbi.nlm.nih.gov/pubmed/33635916
http://dx.doi.org/10.1371/journal.pone.0247805
_version_ 1783655967043354624
author Hirschberg, Daniel
Ekman, Bertil
Wahlberg, Jeanette
Landberg, Eva
author_facet Hirschberg, Daniel
Ekman, Bertil
Wahlberg, Jeanette
Landberg, Eva
author_sort Hirschberg, Daniel
collection PubMed
description Prolactin is a peptide hormone produced in the anterior pituitary, which increase in several physiological and pathological situations. It is unclear if hyperprolactinaemia may affect glycosylation of immunoglobulin G (IgG). Twenty-five patients with hyperprolactinemia and 22 healthy control subjects were included in the study. The groups had similar age and gender distribution. A panel of hormonal and haematological analyses, creatinine, glucose, liver enzymes and immunoglobulins were measured by routine clinical methods. IgG was purified from serum by Protein G Sepharose. Sialic acid was released from IgG by use of neuraminidase followed by quantification on high performance anion-exchange chromatography with pulsed amperometric detection. Tryptic glycopeptides of IgG was analysed by matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Hormone and immunoglobulin levels were similar in the two groups, except for IgA and prolactin. Significantly higher IgG1 and IgG2/3 galactosylation was found in the patient group with hyperprolactinaemia compared to controls. (A significant correlation between prolactin and IgG2/3 galactosylation (Rs 0.61, p<0.001) was found for samples with prolactin values below 2000 mIU/L. The relative amount of sialylated and bisecting glycans on IgG did not differ between patients and controls. The four macroprolactinaemic patients showed decreased relative amount of bisecting IgG2/3 glycans. Hyperprolactinaemia was found to be associated with increased galactosylation of IgG1and IgG2/3. This may have impact on IgG interactions with Fc-receptors, complement and lectins, and consequently lead to an altered immune response.
format Online
Article
Text
id pubmed-7909626
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-79096262021-03-05 Altered immunoglobulin G glycosylation in patients with isolated hyperprolactinaemia Hirschberg, Daniel Ekman, Bertil Wahlberg, Jeanette Landberg, Eva PLoS One Research Article Prolactin is a peptide hormone produced in the anterior pituitary, which increase in several physiological and pathological situations. It is unclear if hyperprolactinaemia may affect glycosylation of immunoglobulin G (IgG). Twenty-five patients with hyperprolactinemia and 22 healthy control subjects were included in the study. The groups had similar age and gender distribution. A panel of hormonal and haematological analyses, creatinine, glucose, liver enzymes and immunoglobulins were measured by routine clinical methods. IgG was purified from serum by Protein G Sepharose. Sialic acid was released from IgG by use of neuraminidase followed by quantification on high performance anion-exchange chromatography with pulsed amperometric detection. Tryptic glycopeptides of IgG was analysed by matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Hormone and immunoglobulin levels were similar in the two groups, except for IgA and prolactin. Significantly higher IgG1 and IgG2/3 galactosylation was found in the patient group with hyperprolactinaemia compared to controls. (A significant correlation between prolactin and IgG2/3 galactosylation (Rs 0.61, p<0.001) was found for samples with prolactin values below 2000 mIU/L. The relative amount of sialylated and bisecting glycans on IgG did not differ between patients and controls. The four macroprolactinaemic patients showed decreased relative amount of bisecting IgG2/3 glycans. Hyperprolactinaemia was found to be associated with increased galactosylation of IgG1and IgG2/3. This may have impact on IgG interactions with Fc-receptors, complement and lectins, and consequently lead to an altered immune response. Public Library of Science 2021-02-26 /pmc/articles/PMC7909626/ /pubmed/33635916 http://dx.doi.org/10.1371/journal.pone.0247805 Text en © 2021 Hirschberg et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Hirschberg, Daniel
Ekman, Bertil
Wahlberg, Jeanette
Landberg, Eva
Altered immunoglobulin G glycosylation in patients with isolated hyperprolactinaemia
title Altered immunoglobulin G glycosylation in patients with isolated hyperprolactinaemia
title_full Altered immunoglobulin G glycosylation in patients with isolated hyperprolactinaemia
title_fullStr Altered immunoglobulin G glycosylation in patients with isolated hyperprolactinaemia
title_full_unstemmed Altered immunoglobulin G glycosylation in patients with isolated hyperprolactinaemia
title_short Altered immunoglobulin G glycosylation in patients with isolated hyperprolactinaemia
title_sort altered immunoglobulin g glycosylation in patients with isolated hyperprolactinaemia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909626/
https://www.ncbi.nlm.nih.gov/pubmed/33635916
http://dx.doi.org/10.1371/journal.pone.0247805
work_keys_str_mv AT hirschbergdaniel alteredimmunoglobulingglycosylationinpatientswithisolatedhyperprolactinaemia
AT ekmanbertil alteredimmunoglobulingglycosylationinpatientswithisolatedhyperprolactinaemia
AT wahlbergjeanette alteredimmunoglobulingglycosylationinpatientswithisolatedhyperprolactinaemia
AT landbergeva alteredimmunoglobulingglycosylationinpatientswithisolatedhyperprolactinaemia